title: Current and emerging therapies for ocular neovascularisation.
abstract: Ocular neovascularisation (ONV) is a pathological feature of many human blinding diseases. Here, we review current pharmacological therapies for these disorders and highlight emerging therapies in clinical trial for ONV. Finally, we discuss desirable characteristics of future ONV therapies, including innovative strategies for novel delivery to the back of the eye.
authors.affiliation: School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland, alison.reynolds@ucd.ie.
authors.forename: Alison L
authors.initials: AL
authors.lastname: Reynolds
authors.forename: David
authors.initials: D
authors.lastname: Kent
authors.forename: Breandán N
authors.initials: BN
authors.lastname: Kennedy
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic; D003930:Diabetic Retinopathy / Q000188:drug therapy*; D016503:Drug Delivery Systems / Q000379:methods*; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy*; D009389:Neovascularization, Pathologic / Q000188:drug therapy*